EXENS Share Price Performance
€0
-44.80 (-100.00%)
Price €0
Fair Value€67.13
Share Pricen/a
Narrative Update • May 24
Exosens Stock Price
- 3 Narratives written by author
- 1 Comments on narratives written by author
- 29 Fair Values set on narratives written by author
EXENS Community Narratives
AN
Fair Value
·Fair Value €67.13 6.7% undervalued intrinsic discount
EXENS: Defense Sector Demand And Shareholder Shift Will Shape Outlook
0users have liked this narrative
0users have commented on this narrative
4users have followed this narrative
AN
Fair Value
·Fair Value €75 16.5% undervalued intrinsic discount
Accelerated Digitization And Expanding Defense Spending Will Spur Sensor Demand
0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
AN
Fair Value
·Fair Value €39.06 60.4% overvalued intrinsic discount
Geopolitical Instability Will Pressure Global Defense Margins
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
Accelerated Digitization And Expanding Defense Spending Will Spur Sensor Demand
Exosens sits in the middle of two big demand waves: growing defense needs and the spread of smarter machines that rely on advanced sensing and imaging. Its global footprint and ability to scale production quickly could help it win share, but the story depends heavily on government spending and staying ahead as rules tighten and technology shifts.Read more
AN
€75
16.5% undervalued intrinsic discount
Fair Value
Revenue
17.64% p.a.
Profit Margin
18.22%
Future PE
33.57x
Price in 2029
€92.33
EXENS: Defense Sector Demand And Shareholder Shift Will Shape Outlook
Key Takeaways Increased global defense spending and Exosens' leadership in advanced sensing technologies support strong and sustained demand across diversified end-markets. Expanded production capacity, product innovation, and financial flexibility position Exosens for long-term growth, operating efficiency, and enhanced profitability.Read more
AN
€67.13
6.7% undervalued intrinsic discount
Fair Value
Revenue
13.61% p.a.
Profit Margin
17.96%
Future PE
33.75x
Price in 2029
€82.42
Geopolitical Instability Will Pressure Global Defense Margins
Key Takeaways Exposure to geopolitical instability, ESG pressures, and reliance on defense make Exosens vulnerable to regulatory, supply chain, and market volatility risks. Failure to innovate and diversify, combined with evolving industry technology, threatens margin erosion and long-term earnings sustainability.Read more
AN
€39.06
60.4% overvalued intrinsic discount
Fair Value
Revenue
13.76% p.a.
Profit Margin
17.27%
Future PE
21.82x
Price in 2029
€47.17
Trending Discussion
Recently Updated Narratives
AN
EXENS: Defense Contracts And Higher Future P E Assumptions Will Support Future Earnings Power
Fair Value: €75 16.5% undervalued intrinsic discount
2 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
EXENS: Defense Backlog And Higher P E Range Will Shape Upside Outlook
Fair Value: €67.13 6.7% undervalued intrinsic discount
4 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
EXENS: Future Defense Contracts Will Still Reveal Extended Overvaluation Risk
Fair Value: €39.06 60.4% overvalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Exosens Key Details
Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
Jul 28, 2026
- 1.38
- 60.06%
- 14.99%
- 56.1%
About EXENS
- Founded
- 1937
- Employees
- 1499
- CEO
- WebsiteView website
Exosens, together with its subsidiaries, develops, manufactures, and sells electro-optical technologies in France, Europe, North America, Asia, and internationally. It operates in two segments, Amplification and Detection and Imaging. The company offers image intensifier tubes; cameras, sensors, modules and cores, and imaging systems and solutions, including UV missile warning solution, atmospheric sounder, and spectroradiometer; and detection and imaging products for ions and electrons, photons, and neutrons, as well as micro pore optics and components, such as phosphor screens, resistive glass products, microchannel plates, and electron generator arrays. It also provides bare and energy compensated Geiger- Müller tubes; gamma and neutron detectors; mineral insulated extensions; and silicon photodiodes, as well as methane airborne detection solutions. The company sells its products under the Exosens, Photonis, Xenics, Telops, El-Mul, and Noxant brand names. It serves defense and surveillance, life sciences and environment, industrial control, and nuclear markets. The company was founded in 1937 and is headquartered in Mérignac, France.
